Zentalis Pharmaceuticals (ZNTL) Amortizatization of Intangibles (2022 - 2026)
Zentalis Pharmaceuticals has reported Amortizatization of Intangibles over the past 5 years, most recently at $224000.0 for Q1 2026.
- For Q1 2026, Amortizatization of Intangibles fell 78.34% year-over-year to $224000.0; the TTM value through Mar 2026 reached $2.0 million, down 68.86%, while the annual FY2025 figure was $2.8 million, 65.47% down from the prior year.
- Amortizatization of Intangibles for Q1 2026 was $224000.0 at Zentalis Pharmaceuticals, down from $431000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $4.6 million in Q4 2023 and troughed at -$146000.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.4 million in 2024 define the central range for Amortizatization of Intangibles.
- Biggest five-year swings in Amortizatization of Intangibles: soared 2397.67% in 2023 and later tumbled 78.34% in 2026.
- Year by year, Amortizatization of Intangibles stood at $2.5 million in 2022, then surged by 83.97% to $4.6 million in 2023, then plummeted by 69.33% to $1.4 million in 2024, then tumbled by 69.15% to $431000.0 in 2025, then crashed by 48.03% to $224000.0 in 2026.
- Business Quant data shows Amortizatization of Intangibles for ZNTL at $224000.0 in Q1 2026, $431000.0 in Q4 2025, and $517000.0 in Q3 2025.